The 2020 academic clinical research activity of the Cooperative Oncology Groups
What is the assessment of COG in 2020 ?
In 2020, the Cooperative Oncology Groups, of which LYSA and its operational structure LYSARC are part, have been able to maintain their objectives in terms of studies, publications, but also clinical studies on patients. Once again this year, the COG have contributed to significant therapeutic advances in many types of cancer, such as ovarian, colon, lung and pleural cancers, as well as lymphomas, in which LYSA and its operational structure at LYSARC are widely involved.
Specialized structures by therapeutic area
Created between 1981 and 2003, the COG are independent, non-profit academic research groups specialized in the field of cancer. Alongside public hospital-based clinical research, which sometimes has difficulty in organizing large national or international trials, the COG facilitate the networking of geographically dispersed experts. They bring together doctors and research professionals from 315 health centers (university hospitals, regional hospitals, hospitals, private institutions) and are specialized by type of cancer: gynecological tumors (ARCAGY-GINECO), digestive (FFCD), digestive and ENT (GERCOR), head and neck (GORTEC), thoracic (IFCT), myeloma and monoclonal gammopathies (IFM), brain tumors (IGCNO-ANOCEF), lymphomas (LYSA and LYSARC), childhood and adolescent cancers and leukemias (SFCE). The CIGAL intergroup, dedicated to adult leukemia, joined the COG network in June 2021.
2020 for the Cooperative Oncology Groups
During the year 2020, all these groups participated in more than 200 ancillary studies. Always with the aim of finding solutions to fight against various cancers, the COG are strengthened year after year with partners, but also with therapeutic innovations.
With 4,500 investigators and 250 employees, the COG have set up 98 clinical studies in which no less than 7,028 patients participated. In 2020, the COG also published 102 papers in referenced journals such as The Lancet, The Lancet Oncol, etc. and 66 oral presentations at leading scientific conferences. In addition, all the results of COG studies are systematically published in leading international scientific journals.